Senior Early-Phase Statistician, Clinical Development

PIERRE FABRE

Occitanie

Sur place

EUR 90 000 - 120 000

Plein temps

Il y a 3 jours
Soyez parmi les premiers à postuler

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Résumé du poste

Pierre Fabre Laboratories seeks a Senior Early Phase Statistician to lead statistics in Clinical Development, guiding first-in-human and proof-of-concept trials from Boulogne or Toulouse. You will design studies, define estimands, and drive adaptive approaches with a matrix team across Clinical Development, Pharmacology, and Data Management.

Applicants should have an advanced statistics degree, 6+ years in pharma/CRO, and strong SAS/R expertise for regulatory-ready analyses and reporting.

Qualifications

  • Advanced degree in Statistics (Master's Degree, ENSAI, ISUP, or PhD) or a related field.
  • A minimum of 6 years of experience in the pharmaceutical industry or a CRO, with significant involvement in clinical trial development from the outset.
  • Previous experience supporting early phase clinical trials, ideally including first-in-human, dose-escalation, dose-expansion, or proof-of-concept studies
  • Advanced statistical analysis skills
  • Proficiency in at least one of the following two statistical software: SAS or R
  • Strong understanding of clinical trial design and methodology
  • Knowledge of methodologies relevant to early clinical development, such as Bayesian methods, adaptive designs, dose-escalation methods

Responsabilités

  • Participate in the conception and design of early phase clinical trials, including first-in-human, dose-escalation, dose-expansion, and proof-of-concept studies.
  • Provide expert statistical input into objective definitions, endpoints, estimands, analysis populations, and sample size considerations.
  • Contribute to dose-escalation and dose-optimization strategies, including model-based, model-assisted, Bayesian, or adaptive approaches.
  • Collaborate with clinicians to integrate safety, PK/PD, biomarkers, and preliminary efficacy data.
  • Support quantitative decision criteria for dose selection, cohort expansion, proof of mechanism, and Go/No-Go decisions.
  • Act as the primary statistical contact for assigned projects and attend study meetings.
  • Draft/validate key study documents and SAPs; ensure timely deliverables.
  • Program/validate analyses using SAS and/or R.
  • Assist with regulatory responses and summaries for agencies.
  • Contribute to CRO selection and evaluation; ensure cost, timeline, and data quality.
  • Oversee statistical documentation within the team and outsourced activities to CROs.
  • Follow industry standards and ensure eTMF inclusion for statistics-related documents.

Connaissances

Statistics degree
Clinical trial experience
Early phase trials
Advanced statistics
SAS or R
Bayesian methods
Adaptive designs

Formation

Advanced degree in Statistics

Outils

SAS
R

Description du poste

Pierre Fabre Laboratories seeks a Senior Early Phase Statistician to lead statistics in Clinical Development, guiding first-in-human and proof-of-concept trials from Boulogne or Toulouse. You will design studies, define estimands, and drive adaptive approaches with a matrix team across Clinical Development, Pharmacology, and Data Management.

Applicants should have an advanced statistics degree, 6+ years in pharma/CRO, and strong SAS/R expertise for regulatory-ready analyses and reporting.

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Senior Early Phase Statistician Clinical Development Hybrid
Senior Early Phase Statistician Clinical Development Hybrid

Pierre Fabre Pharmaceuticals, Inc. • Boulogne, Toulouse

Hybride
EUR 90 000 - 120 000
Profit-sharing
Shareholding with matchingContribution
Health and provident insurance
+1
Senior Early-Phase Statistician - Hybrid (Remote/Onsite)
Senior Early-Phase Statistician - Hybrid (Remote/Onsite)

PIERRE FABRE MEDICAMENT • Pechbusque

Hybride
EUR 90 000 - 130 000
Teleworking up to 2 days/week
Health and provident insurance
25 days holidays + RTT
Senior Phase II/III Statistician — Regulatory Strategy
Senior Phase II/III Statistician — Regulatory Strategy

PIERRE FABRE MEDICAMENT • Pechbusque

Sur place
EUR 90 000 - 120 000
Incentives
Profit-sharing
Pierre Fabre shareholding with matched
+2
Senior Early-Phase Statistician — Hybrid (Remote 2d/wk)
Senior Early-Phase Statistician — Hybrid (Remote 2d/wk)

Laboratoires Pierre Fabre • Boulogne-Billancourt

Hybride
EUR 90 000 - 130 000
Incentives
Profit-sharing
Shareholding with matching
+4
Senior Late-Phase Statistician – Oncology, Regulatory Leader
Senior Late-Phase Statistician – Oncology, Regulatory Leader

Pierre Fabre Laboratories • Boulogne-Billancourt

Sur place
EUR 90 000 - 130 000
Incentives
Profit-sharing
Pierre Fabre shareholding with match
+3
Early Phase Statistician - Clinical Development- M/F- CDI
Early Phase Statistician - Clinical Development- M/F- CDI

PIERRE FABRE • Occitanie

Sur place
EUR 90 000 - 120 000
Senior Biostatistician, Phase II/III, Hybrid (Oncology)
Senior Biostatistician, Phase II/III, Hybrid (Oncology)

Pierre Fabre Laboratories • Île-de-France

Sur place
EUR 90 000 - 125 000
Profit-sharing
Health and provident insurance
25 days + RTT holidays
Senior Late-Phase Statistician — Hybrid/Remote
Senior Late-Phase Statistician — Hybrid/Remote

Pierre Fabre • Toulouse

Hybride
EUR 90 000 - 130 000
Télétravail partiel
Avantages attractifs
Senior Early Phase Statistician – Clinical Development- M/F
Senior Early Phase Statistician – Clinical Development- M/F

Laboratoires Pierre Fabre • Boulogne-Billancourt

Hybride
EUR 90 000 - 130 000
Incentives
Profit-sharing
Shareholding with matching
+4
Late Phase Statistician - Clinical Development- M/F
Late Phase Statistician - Clinical Development- M/F

Laboratoires Pierre Fabre • Boulogne-Billancourt

Sur place
EUR 90 000 - 130 000
Incentives
Profit-sharing
Pierre Fabre shareholding with match
+3